Pharmaceutical manufacturer
HR 2853 BLOCKING Act of 2021 (All sections of full text)

Discussions regarding the approval of generic drugs

Monitored H.R.5376, Build Back Better Act 

Monitored the implementation of P.L.117-7, To prevent across-the-board direct spending cuts, and for other purposes

Monitored Medicare and prescription drug changes
HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE SMITH-FREE GROUP, LLC
1401 K Street NW Suite 1200, Washington, DC, 20005, US
JACK S DEUSER JAMES C FREE MICHAEL A. GAFFIN ROBERT HICKMOTT TREVOR W. KOLEGO